"The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor.
GCTB generally occurs in a"...
Patients should be advised:
- of the potential benefits and risks of Triglide.
- not to use Triglide if there is a known hypersensitivity to fenofibrate or fenofibric acid.
- of medications that should not be taken in combination with Triglide.
- that if they are taking coumarin anticoagulants, Triglide may increase their anti-coagulant effect, and increased monitoring may be necessary.
- to inform their physician of all medications, supplements, and herbal preparations they are taking and any change in their medical condition.
- to inform a physician prescribing a new medication, that they are taking Triglide.
- to continue to follow an appropriate lipid-modifying diet while taking Triglide.
- to take Triglide once daily at the prescribed dose, swallowing each tablet whole.
- to inform their physician of any muscle pain, tenderness, or weakness; onset of abdominal pain; or any other new symptoms.
- to return to their physician's office for routine monitoring.
Last reviewed on RxList: 2/15/2013
This monograph has been modified to include the generic and brand name in many instances.
Additional Triglide Information
Triglide - User Reviews
Triglide User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Find out what women really need.